Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative

BACKGROUND: Hepatitis B e Antigen (HBeAg)-negative chronic hepatitis B (CHB) patients have an active liver disease with a high risk of progression to decompensated cirrhosis and hepatocellular carcinoma. The management strategy for HBeAg-negative CHB patients treated with nucleos(t)ide analogues (NU...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: He, Dengming, Guo, Shimin, Chen, Wen, Chen, Xianli, Yan, Guohua, Wang, Jie, Li, Maoshi, Zhu, Peng, Huang, Hongfei, Wang, Yuming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850530/
https://ncbi.nlm.nih.gov/pubmed/24090287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-13-458
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller